Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-21-007377

Director acquired 14,632 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Mehra Anand Director 2021-02-02 Option exercise +8,000 $18.35 $146,800 24,209 D
Mehra Anand Director 2021-02-02 Option exercise +6,632 $18.32 $121,498 30,841 D
Derivatives
Mehra Anand Director 2021-02-02 Option exercise · Option Grant (right to buy) −8,000 0 D
Mehra Anand Director 2021-02-02 Option exercise · Option Grant (right to buy) −6,632 0 D
Loading xslF345X03/doc4.xml…